Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure

Journal of Clinical Investigation

Volumn 115, Issue 5, 2005, Pages 1275-1280

  Xu, Jianchao ^a,b,c   Li, Guoyong ^a,b,c   Wang, Peili ^a,b,c   Velazquez, Heino ^a,b,c   Yao, Xiaoqiang ^d   Li, Yanyan ^a,b,c   Wu, Yanling ^a,b,c   Peixoto, Aldo ^a,b,c   Crowley, Susan ^a,b,c   Desir, Gary V ^a,b,c  

^a Section of Nephrology   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c West Haven Campus   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATECHOLAMINE; DINUCLEOTIDE; QUERCETIN; RENALASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME RELEASE; GENE EXPRESSION; HEART; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; IN VITRO STUDY; KIDNEY; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SMALL INTESTINE;

EID: 20944444468     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24066     Document Type: Article

References (23)

1. Brenner, B.M., Deen, W.M., and Robertson, C.R. 1976. Determinants of glomerular filtration rate. Annu. Rev. Physiol. 38:11-19.
2. Lin, F.K., et al. 1985. Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 82:7580-7584.
3. Jacobs, K., et al. 1985. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature. 313:806-810.
4. Persson, P.B. 2003. Renin: origin, secretion and synthesis. J. Physiol. 552:667-671.
5. Humes, H.D. 1995. Acute renal failure: prevailing challenges and prospects for the future. Kidney Int. Suppl. 50:S26-S32.
6. Wolfe, R.A., et al. 1999. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341:1725-1730.
7. Oberg, B.P., et al. 2004. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 65:1009-1016.
8. Koomans, H.A., Blankestijn, P.J., and Joles, J.A. 2004. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J. Am. Soc. Nephrol. 15:524-537.
9. Joles, J.A., and Koomans, H.A. 2004. Causes and consequences of increased sympathetic activity in renal disease. Hypertension. 43:699-706.
10. Strausberg, R.L., Feingold, E.A., Klausner, R.D., and Collins, F.S. 1999. The mammalian gene collection. Science. 286:455-457.
11. Liang, X., et al. 2002. Transcriptionally active polymerase chain reaction (TAP): high throughput gene expression using genome sequence data. J. Biol. Chem. 277:3593-3598.
12. Binda, C., Newton-Vinson, P., Hubalek, F., Edmondson, D.E., and Mattevi, A. 2002. Structure of human monoamine oxidase B, a drug target fot the treatment of neurological disorders. Nat. Struct. Biol. 9:22-26.
13. Jalkanen, S., and Salmi, M. 2001. Cell surface monoamine oxidases: enzymes in search of a function. EMBO J. 20:3893-3901.
14. Binda, C., Mattevi, A., and Edmondson, D.E. 2002. Structure-function relationships in flavoenzyme-dependent amine oxidations: a comparison of polyamine oxidase and monoamine oxidase. J. Biol. Chem. 277:23973-23976.
15. Salmi, M., and Jalkanen, S. 2001. VAP-1: an adhesin and an enzyme. Trends Immunol. 22:211-216.
16. Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E., and Hsu, C.Y. 2004. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351:1296-1305.
17. Anavekar, N.S., et al. 2004. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N. Engl. J. Med. 351:1285-1295.
18. Hostetter, T.H. 2004. Chronic kidney disease predicts cardiovascular disease. N. Engl. J. Med. 351:1344-1346.
19. Zoccali, C., et al. 2002. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease. Hypertension. 40:41-46.
20. Zoccali, C., et al. 2002. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 105:1354-1359.
21. Hausberg, M., et al. 2002. Sympathetic nerve activity in end-stage renal disease. Circulation. 106:1974-1979.
22. Tian, S., et al. 2002. Regulation of the voltage-gated K(+) channei KCNA10 by KCNA4B, a novel beta-subunit. Am. J. Physiol. Renal. Physiol. 283:F142-F149.
23. Yao, X., Tian, S., Chan, H.-Y., Biemesderfer, D., and Desir, G. 2002. Expression of KCNA10, a voltage-gated K channel, in glomerular endothelium and at the apical membrane of the renal proximal tubule. J. Am. Soc. Nephrol. 13:2831-2839.